Search Google News for the latest updates on Eli Lilly's evaluation of Peptron's SmartDepot technology and any potential licensing deals.

AI-powered analysis for: Search Google News for the latest updates on Eli Lilly's evaluation of Peptron's SmartDepot technology and any potential licensing deals.. Get detailed insights and real-time data on PolyPredict AI.

Explain the difference between a co-development agreement (resolves 'No') and a commercial licensing agreement (resolves 'Yes') for this Peptron event in simple terms.

AI-powered analysis for: Explain the difference between a co-development agreement (resolves 'No') and a commercial licensing agreement (resolves 'Yes') for this Peptron event in simple terms.. Get detailed insights and real-time data on PolyPredict AI.

Check upcoming Eli Lilly earnings calls or Peptron corporate events before October 7 to see if a licensing announcement might be scheduled.

AI-powered analysis for: Check upcoming Eli Lilly earnings calls or Peptron corporate events before October 7 to see if a licensing announcement might be scheduled.. Get detailed insights and real-time data on PolyPredict AI.

Identify the key executives at Eli Lilly and Peptron responsible for finalizing the SmartDepot commercial licensing agreement.

AI-powered analysis for: Identify the key executives at Eli Lilly and Peptron responsible for finalizing the SmartDepot commercial licensing agreement.. Get detailed insights and real-time data on PolyPredict AI.

Search for regulatory or corporate hurdles that could delay Eli Lilly from converting their current Technology Evaluation Agreement with Peptron into a full commercial license.

AI-powered analysis for: Search for regulatory or corporate hurdles that could delay Eli Lilly from converting their current Technology Evaluation Agreement with Peptron into a full commercial license.. Get detailed insights and real-time data on PolyPredict AI.

Verify where official corporate announcements from Peptron and Eli Lilly are published to reliably monitor the SmartDepot licensing status.

AI-powered analysis for: Verify where official corporate announcements from Peptron and Eli Lilly are published to reliably monitor the SmartDepot licensing status.. Get detailed insights and real-time data on PolyPredict AI.

List the top 3 bearish arguments on why Eli Lilly might choose NOT to license Peptron's SmartDepot technology by the October deadline.

AI-powered analysis for: List the top 3 bearish arguments on why Eli Lilly might choose NOT to license Peptron's SmartDepot technology by the October deadline.. Get detailed insights and real-time data on PolyPredict AI.

Search Twitter for recent sentiment from biotech analysts regarding the likelihood of Eli Lilly signing a binding tech transfer agreement with Peptron.

AI-powered analysis for: Search Twitter for recent sentiment from biotech analysts regarding the likelihood of Eli Lilly signing a binding tech transfer agreement with Peptron.. Get detailed insights and real-time data on PolyPredict AI.

What upcoming clinical trial results or biotech conferences in the next 48 hours could trigger volatility in the Peptron-Eli Lilly licensing odds?

AI-powered analysis for: What upcoming clinical trial results or biotech conferences in the next 48 hours could trigger volatility in the Peptron-Eli Lilly licensing odds?. Get detailed insights and real-time data on PolyPredict AI.

If no official announcement is made by Eli Lilly or Peptron by October, which side (Yes/No) benefits more from time decay?

AI-powered analysis for: If no official announcement is made by Eli Lilly or Peptron by October, which side (Yes/No) benefits more from time decay?. Get detailed insights and real-time data on PolyPredict AI.

Compare this potential Eli Lilly/Peptron deal with Eli Lilly's past licensing timelines after initial technology evaluations to see if the October 7 deadline is realistic.

AI-powered analysis for: Compare this potential Eli Lilly/Peptron deal with Eli Lilly's past licensing timelines after initial technology evaluations to see if the October 7 deadline is realistic.. Get detailed insights and real-time data on PolyPredict AI.

Summarize the core disagreements in the prediction market community regarding whether recent Peptron announcements qualify as a 'binding commercial agreement'.

AI-powered analysis for: Summarize the core disagreements in the prediction market community regarding whether recent Peptron announcements qualify as a 'binding commercial agreement'.. Get detailed insights and real-time data on PolyPredict AI.

Analyze whether Eli Lilly's tech licensing decisions follow predictable corporate timelines or if the exact timing of this SmartDepot deal is purely random.

AI-powered analysis for: Analyze whether Eli Lilly's tech licensing decisions follow predictable corporate timelines or if the exact timing of this SmartDepot deal is purely random.. Get detailed insights and real-time data on PolyPredict AI.

Assess the slippage risk for a $1,000 order in this Eli Lilly/Peptron market based on the current bid-ask spread and extremely low volume.

AI-powered analysis for: Assess the slippage risk for a $1,000 order in this Eli Lilly/Peptron market based on the current bid-ask spread and extremely low volume.. Get detailed insights and real-time data on PolyPredict AI.

Evaluate if the current odds offer enough premium to offset the rule risk of an agreement being classified as 'co-development' instead of a 'commercial license'.

AI-powered analysis for: Evaluate if the current odds offer enough premium to offset the rule risk of an agreement being classified as 'co-development' instead of a 'commercial license'.. Get detailed insights and real-time data on PolyPredict AI.

Based on the bid-ask spread for the Eli Lilly/Peptron licensing event, suggest an optimal limit order price that maximizes value without losing execution edge.

AI-powered analysis for: Based on the bid-ask spread for the Eli Lilly/Peptron licensing event, suggest an optimal limit order price that maximizes value without losing execution edge.. Get detailed insights and real-time data on PolyPredict AI.

Suggest a portfolio allocation percentage using the Kelly criterion for betting on Eli Lilly successfully licensing SmartDepot by October 7.

AI-powered analysis for: Suggest a portfolio allocation percentage using the Kelly criterion for betting on Eli Lilly successfully licensing SmartDepot by October 7.. Get detailed insights and real-time data on PolyPredict AI.

Suggest a fundamental red line (e.g., Eli Lilly officially extending the evaluation agreement without commercial rights) that should trigger an immediate stop-loss.

AI-powered analysis for: Suggest a fundamental red line (e.g., Eli Lilly officially extending the evaluation agreement without commercial rights) that should trigger an immediate stop-loss.. Get detailed insights and real-time data on PolyPredict AI.

Recommend 3 other assets or prediction markets (such as Peptron's stock ticker) that are strongly correlated with this Eli Lilly licensing event.

AI-powered analysis for: Recommend 3 other assets or prediction markets (such as Peptron's stock ticker) that are strongly correlated with this Eli Lilly licensing event.. Get detailed insights and real-time data on PolyPredict AI.

Calculate if tying up capital in this low-volume Eli Lilly/Peptron market until October 7 is worth the potential return compared to risk-free DeFi yields.

AI-powered analysis for: Calculate if tying up capital in this low-volume Eli Lilly/Peptron market until October 7 is worth the potential return compared to risk-free DeFi yields.. Get detailed insights and real-time data on PolyPredict AI.

Eli Lilly licenses Peptron’s SmartDepot by October 7?

Tech|$4,046 Vol|

152 days 16 hrs

Eli Lilly licenses Peptron’s SmartDepot by October 7? - AI Found +19.5¢ Mispricing

AI Signal Dashboard

Last updated: 05.06 01:15

Top Undervalued

+19.5¢

(No)

Eli Lilly licenses Peptron’s SmartDepot by October 7? AI analysis: • +19.5¢ undervalued • Live Prediction Market fair value & mispricing alerts.

Undervalued Options Insights:

This event predicts whether Eli Lilly will secure a commercial license for Peptron's SmartDepot tech...

🔓 Log in to see more

All Outcomes

Market Price

AI Fair Value

Value Edge

YesNo

54.5¢

45.5¢

35¢

65¢

0¢

+19.5¢

⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.

Rule Risk

The rules explicitly exclude co-development agreements or extensions of existing technology evaluation agreements. Headlines announcing a 'partnership' might easily mislead headline-driven traders if direct commercial rights are not strictly granted.

Hedging

087010

Eli Lilly (LLY) has a massive market cap, meaning this single drug delivery technology licensing deal would have a very limited marginal impact on its stock. However, for the smaller-cap Peptron (KOSDAQ: 087010), securing a commercial license from a global pharma giant is a structural catalyst that would trigger extreme upward price revaluation.